Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
15.07
+0.97 (6.88%)
At close: Nov 6, 2026, 4:00 PM EST
15.37
+0.30 (1.99%)
After-hours: Nov 6, 2026, 6:16 PM EST
Jade Biosciences Employees
Jade Biosciences had 55 employees as of December 31, 2025. The number of employees increased by 25 or 83.33% compared to the previous year. That makes Jade Biosciences the 34,576th largest employer in the world and 4,602nd in the United States.
Employees
55
Change (1Y)
25
Growth (1Y)
83.33%
Revenue / Employee
n/a
Profits / Employee
-$2,262,582
Market Cap
958.41M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 55 | 25 | 83.33% |
| Dec 31, 2024 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 704 |
| MeiraGTx Holdings | 393 |
| Syndax Pharmaceuticals | 298 |
| Rigel Pharmaceuticals | 174 |
| Monte Rosa Therapeutics | 173 |
| MoonLake Immunotherapeutics | 130 |
| ORIC Pharmaceuticals | 111 |
| Odyssey Therapeutics | 100 |
JBIO News
- 3 days ago - Jade Biosciences to Participate in Upcoming Conferences - GlobeNewsWire
- 16 days ago - Jade Biosciences to Highlight Advancement of JADE101 Development Program at American Society of Nephrology (ASN) Kidney Week 2026 - GlobeNewsWire
- 18 days ago - Jade Biosciences management to meet with BTIG - TheFly
- 5 weeks ago - Jade Biosciences Transcript: Study update - Transcripts
- 5 weeks ago - Jade Biosciences Press release: Study update - Filings
- 5 weeks ago - Jade Biosciences Slides: Study update - Filings
- 5 weeks ago - Jade Biosciences announces preclinical data of JADE301 - TheFly
- 5 weeks ago - Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026 - GlobeNewsWire